Table 1.
Patient characteristics are presented as absolute number, n, and percentage or as median and interquartile range.
| Patient Characteristics | Patients n/(%) |
HCW n/(%) |
p-Value |
|---|---|---|---|
| Total patient number | 110 | 80 | - |
| Sex (male/female) | 50 (50)/55 (50) | 20 (25)/60 (75) | 0.001 |
| Child A/Child B/Child C | 76 (69)/31 (28)/3 (3) | - | |
| SARS-CoV-2 IgG detectability rate | 106 (96) | 79 (99) | 0.40 |
| Median (IQR) | Median (IQR) | ||
| MELD score at first vaccination | 10 (8–13) | - | - |
| Age at first vaccination [years] | 55 (45–61) | 54 (45–59) | 0.19 |
| Time between first and second doses [days] | 42 (35–42) | 44 (22–47) | 0.39 |
| Time between second dose and SARS-CoV-2 Ab detection [days] | 69 (43–106) | 56 (38–90) | 0.20 |
| SARS-CoV-2 IgG (BAU/mL) | 939 (307 to >2080) | 1905 (996.3 to >2080) | 0.0001 |
Ab: antibody, BAU: binding antibody units, HCW: healthcare workers, IQR: interquartile range, MELD: model of end-stage liver disease; SARS-CoV-2: severe acute respiratory syndrome coronavirus type 2.